Literature DB >> 9817257

Laparoscopic versus open splenectomy for immune thrombocytopenic purpura.

R R Lozano-Salazar1, M F Herrera, F Vargas-Vorácková, X López-Karpovitch.   

Abstract

BACKGROUND: Laparoscopic splenectomy (LS) has been proposed as a substitute to open splenectomy (OS) in the treatment of immune thrombocytopenic purpura (ITP). The aim of this study was to compare two cohorts of patients with ITP who underwent OS or LS. PATIENTS AND METHODS: From February 1990 to January 1997, 27 patients underwent OS and 22 LS. Perioperative characteristics, outcomes, and complications were comparatively analyzed.
RESULTS: Mean age was 38 years (+/- 16) in the OS group, and 39 (+/- 16) in the LS group; the male: female ratio was 1:2 in both groups. Median preoperative platelet count was 16 x 10(9)/L (range 2 to 186 x 10(9)/L) in the OS group, and 50 x 10(9)/L (2 to 241 x 10(9)/L) in the LS group. Mean operative time was 2.7 hours (+/- 0.7) for OS, and 4.5 hours (+/- 1) for LS (P <0.0001). Two conversions to laparotomy occurred in the LS group. A total of 14 complications occurred in 10 patients of the OS group; 8 complications occurred in 6 patients of the LS group. Two patients died in the OS group and 1 in the LS group. Mean postoperative discharge was 6 days (3 to 44) in the OS group and 4 days (2 to 11) in the LS group (P <0.02). Response rates were similar in both groups.
CONCLUSIONS: Laparoscopic splenectomy is comparable to OS in terms of efficacy and safety, and it is associated with a shorter hospital stay.

Entities:  

Mesh:

Year:  1998        PMID: 9817257     DOI: 10.1016/s0002-9610(98)00209-8

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  12 in total

1.  Predictors of response after laparoscopic splenectomy for immune thrombocytopenic purpura.

Authors:  N Katkhouda; S W Grant; E Mavor; M H Friedlander; R V Lord; K Achanta; R Essani; R Mason
Journal:  Surg Endosc       Date:  2001-02-06       Impact factor: 4.584

2.  Prevention and management of complications of laparoscopic splenectomy.

Authors:  Deepraj S Bhandarkar; Avinash N Katara; Gaurav Mittal; Rasik Shah; Tehemton E Udwadia
Journal:  Indian J Surg       Date:  2011-07-27       Impact factor: 0.656

3.  A meta-analysis of perioperative outcomes of laparoscopic splenectomy for hematological disorders.

Authors:  Yan-Nan Bai; Hui Jiang; Pankaj Prasoon
Journal:  World J Surg       Date:  2012-10       Impact factor: 3.352

4.  Splenectomy in Patients with Visceral Leishmaniasis Resistant to Conventional Therapy and Secondary Prophylaxis: A Retrospective Cohort.

Authors:  Luis G C Reinaldo; Raimundo J C Araújo-Júnior; Thiago M Diniz; Rafael D Moura; Antônio J Meneses-Filho; Caio V V M Furtado; Washington L C Santos; Dorcas L Costa; Kelsen D Eulálio; Gabriel R Ferreira; Carlos H N Costa
Journal:  Am J Trop Med Hyg       Date:  2022-06-20       Impact factor: 3.707

5.  Long-term outcomes of laparoscopic versus open splenectomy for immune thrombocytopenia.

Authors:  Kazuhiro Tada; Masayuki Ohta; Kunihiro Saga; Hiroomi Takayama; Teijiro Hirashita; Yuichi Endo; Hiroki Uchida; Yukio Iwashita; Masafumi Inomata
Journal:  Surg Today       Date:  2017-07-19       Impact factor: 2.549

6.  Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  B Habermalz; S Sauerland; G Decker; B Delaitre; J-F Gigot; E Leandros; K Lechner; M Rhodes; G Silecchia; A Szold; E Targarona; P Torelli; E Neugebauer
Journal:  Surg Endosc       Date:  2008-02-22       Impact factor: 4.584

7.  Hematological long-term results of laparoscopic splenectomy for patients with idiopathic thrombocytopenic purpura: a case control study.

Authors:  F J Berends; N Schep; M A Cuesta; H J Bonjer; M C Kappers-Klunne; P Huijgens; G Kazemier
Journal:  Surg Endosc       Date:  2004-02-02       Impact factor: 4.584

8.  Laparoscopic splenectomy reduces the need for platelet transfusion in patients with idiopathic thrombocytopenic purpura.

Authors:  Rosario Vecchio; Emma Cacciola; Giuseppe Lipari; Valeria Privitera; Chiara Polino; Rossella Cacciola
Journal:  JSLS       Date:  2005 Oct-Dec       Impact factor: 2.172

9.  Laparoscopic splenectomy in the management of benign and malignant hematologic diseases.

Authors:  Gianfranco Silecchia; Cristian Eugeniu Boru; Aldo Fantini; Luigi Raparelli; Francesco Greco; Mario Rizzello; Alessandro Pecchia; Paolo Fabiano; Nicola Basso
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

10.  Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.

Authors:  Susan D Mathias; Sue K Gao; Kimberly L Miller; David Cella; Claire Snyder; Ralph Turner; Albert Wu; James B Bussel; James N George; Robert McMillan; Diane Kholos Wysocki; Janet L Nichol
Journal:  Health Qual Life Outcomes       Date:  2008-02-08       Impact factor: 3.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.